Characterization of a novel inhibitor of cytosolic phospholipase A2alpha, pyrrophenone.
about
Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic interventionGroup IV phospholipase A(2)alpha controls the formation of inter-cisternal continuities involved in intra-Golgi transportNovel contraceptive targets to inhibit ovulation: the prostaglandin E2 pathwayArachidonic acid release from mammalian cells transfected with human groups IIA and X secreted phospholipase A(2) occurs predominantly during the secretory process and with the involvement of cytosolic phospholipase A(2)-alpha.Localization and function of cytosolic phospholipase A2alpha at the Golgi.A bifunctional role for group IIA secreted phospholipase A2 in human rheumatoid fibroblast-like synoviocyte arachidonic acid metabolismGroup IVA phospholipase A2 regulates testosterone biosynthesis by murine Leydig cells and is required for timely sexual maturation.Study of the role of cytosolic phospholipase A2 alpha in eicosanoid generation and thymocyte maturation in the thymusBinding conformation of 2-oxoamide inhibitors to group IVA cytosolic phospholipase A2 determined by molecular docking combined with molecular dynamics.Phospholipase A2IVα regulates phagocytosis independent of its enzymatic activitySimultaneous activation of p38 and JNK by arachidonic acid stimulates the cytosolic phospholipase A2-dependent synthesis of lipid droplets in human monocytes.Cytosolic phospholipase A2α regulates G1 progression through modulating FOXO1 activityCytosolic phospholipase A2alpha activation induced by S1P is mediated by the S1P3 receptor in lung epithelial cells.Cytosolic phospholipase A2-alpha: a potential therapeutic target for prostate cancerGroup IVA cytosolic phospholipase A2 (cPLA2alpha) and integrin alphaIIbbeta3 reinforce each other's functions during alphaIIbbeta3 signaling in plateletsGolgi-associated cPLA2alpha regulates endothelial cell-cell junction integrity by controlling the trafficking of transmembrane junction proteins.Location of inhibitors bound to group IVA phospholipase A2 determined by molecular dynamics and deuterium exchange mass spectrometry.Orexin/hypocretin receptor signalling cascades.Roles of ERK and cPLA2 in the angiotensin II-mediated biphasic regulation of Na+-HCO3(-) transport.Effects of the inhibition of cytosolic phospholipase A(2)α in non-small cell lung cancer cells.Differential inhibition of group IVA and group VIA phospholipases A2 by 2-oxoamides.PGE2 release is independent of upregulation of Group V phospholipase A2 during long-term stimulation of P388D1 cells with LPS.Characterization of prostaglandin E2 generation through the cyclooxygenase (COX)-2 pathway in human neutrophils.2-Oxoamide inhibitors of cytosolic group IVA phospholipase A2 with reduced lipophilicity.The cationic cluster of group IVA phospholipase A2 (Lys488/Lys541/Lys543/Lys544) is involved in translocation of the enzyme to phagosomes in human macrophages.Effects of pyrrophenone, an inhibitor of group IVA phospholipase A2, on eicosanoid and PAF biosynthesis in human neutrophils.Off-target effect of the cPLA2α inhibitor pyrrophenone: Inhibition of calcium release from the endoplasmic reticulumA New Generation of Arachidonic Acid Analogues as Potential Neurological Agent Targeting Cytosolic Phospholipase A2.Flow cytometric analysis of ca-induced membrane permeability transition of isolated rat liver mitochondria.Involvement of calcium-independent phospholipase A2 in hydrogen peroxide-induced accumulation of free fatty acids in human U937 cells.In vivo phospholipase activity of the Pseudomonas aeruginosa cytotoxin ExoU and protection of mammalian cells with phospholipase A2 inhibitors.Regulation of calcium release from the endoplasmic reticulum by the serine hydrolase ABHD2.Calcium-independent phospholipase A2-mediated formation of 1,2-diarachidonoyl-glycerophosphoinositol in monocytes.Calcium-independent phospholipase A2 mediates proliferation of human promonocytic U937 cells.Arachidonic acid regulates the translocation of 5-lipoxygenase to the nuclear membranes in human neutrophils.Sustained activation of proton channels and NADPH oxidase in human eosinophils and murine granulocytes requires PKC but not cPLA2 alpha activity.Selectivity of cytosolic phospholipase A2 type IV toward arachidonyl phospholipids.pCRP-mCRP Dissociation Mechanisms as Potential Targets for the Development of Small-Molecule Anti-Inflammatory Chemotherapeutics.
P2860
Q26997377-98109A82-C62D-40F9-AC5D-3F755736069DQ27329064-1A864C07-9AA5-4D12-B3E1-3280F0A287A9Q28083349-A0691342-B15C-4763-8E4A-244CA991ECB5Q33199057-A5E0B91F-9DE8-4F8A-8AB0-9BE741631F24Q33886424-E2760E87-1069-4A1D-885E-1AD93672F026Q34509270-5D52F394-9AEF-40E8-B330-9D7C0FBE76D2Q35213041-1806AC93-270F-49BC-A3AB-9233E1A0C133Q35630273-A66E7AB6-F6E0-48F2-803C-1CC510F30B19Q35691760-16023504-D27D-4278-BD00-56F3711EB2DEQ35956700-45752DA1-4661-4AC9-9DE5-8D5B7FD1211AQ36302741-04B0E532-C1C9-4BB9-8115-CE666601A946Q36570938-27A28D10-BDC1-4AF1-9C69-933CB50DA1EDQ36846444-D36AF60A-FB55-4AB1-8C7A-7BC2194F5556Q37020802-F02B23A5-1713-4EFE-B473-ED05704A85EEQ37041937-8EFBB74B-B1FD-41AF-9BBB-41E56B709C3BQ37369889-FF32A848-4F67-4553-9D25-AEB3E55FB6A4Q37389172-54F5632B-C3D0-4EB3-B7CD-A45F90147923Q38125537-3BE2408A-6AFD-4DE2-A841-7B1BA1116049Q38624822-3EABC8F8-7469-42A1-A89C-2067B0107F1CQ39406853-D404C687-7BC1-4417-81A3-3F4FB57D7097Q40287484-439A1F5B-0C18-40EE-BD31-1EDFF48EA7EEQ40375894-D5E29BE7-36BA-40B0-BA4F-B386044EAF5BQ41446246-E82FDC82-6A72-4A8F-96AB-5741A73AA21EQ41634441-6BFF5FDD-C9C3-4212-BFAC-D3157CB63B23Q42085185-E1CDB36D-748A-45C1-B6EC-2CFE66A7E4C0Q42370163-61B0015C-3509-478E-84A5-E1714F4D1D7FQ42383395-F996F1E9-5571-4E02-80A2-A2D2BB859DC3Q42653060-8243CCA4-25F0-4E08-B6CA-A674C9D0B1BFQ42971680-2A748F5B-763B-40EC-A0A8-D8B5490813C6Q44104185-E790367A-2653-4974-88F8-BF04BAF4BFA1Q44547313-ABF972FC-12EC-49D8-AC9B-C95BEC10283BQ45062800-F464A623-EB17-42F2-8DCD-3AFA197AC7C7Q46240064-1455BDFB-FF26-421B-A4A6-F7E9AA5619B1Q46705705-C9D60939-CC42-4D46-9D09-17ADCDE5985DQ46794842-6D2F6D28-0797-4677-A0A8-9FE7D3EAC3E8Q52575826-C84A6578-F47B-44AF-9501-220F10141B0DQ53308126-66526F5A-71E8-45C5-97FE-B6B03A9F09B9Q55044803-0F2D10C3-49E9-4262-8867-73F5049B7EB4
P2860
Characterization of a novel inhibitor of cytosolic phospholipase A2alpha, pyrrophenone.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Characterization of a novel inhibitor of cytosolic phospholipase A2alpha, pyrrophenone.
@en
type
label
Characterization of a novel inhibitor of cytosolic phospholipase A2alpha, pyrrophenone.
@en
prefLabel
Characterization of a novel inhibitor of cytosolic phospholipase A2alpha, pyrrophenone.
@en
P2093
P2860
P1433
P1476
Characterization of a novel inhibitor of cytosolic phospholipase A2alpha, pyrrophenone.
@en
P2093
Kaoru Seno
Katsutoshi Yamada
Masahiko Ueno
Shozo Nakamoto
Takashi Ono
Takayuki Okuno
Yukiko Chikazawa
P2860
P304
P356
10.1042/0264-6021:3630727
P407
P577
2002-05-01T00:00:00Z